Alan Colman - Jul 5, 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Director
Signature
/s/ Alan Colman
Stock symbol
VNRX
Transactions as of
Jul 5, 2023
Transactions value $
$0
Form type
4
Date filed
7/7/2023, 04:03 PM
Previous filing
Jan 13, 2023
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +6.75K +3.94% $0.00 178K Jul 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 4, 2022, the reporting person was awarded 15,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 6,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 2,250 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 2,625 RSUs and 5,625 RSUs subject to the award previously vested and remain subject to time-based vesting.